Trials / Conditions / Non-Hodgkin Lymphoma Refractory/ Relapsed
Non-Hodgkin Lymphoma Refractory/ Relapsed
5 registered clinical trials studyying Non-Hodgkin Lymphoma Refractory/ Relapsed — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946 | LTZ Therapeutics, Inc. | Phase 1 |
| Recruiting | A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy NCT07188558 | Lyell Immunopharma, Inc. | Phase 3 |
| Recruiting | Amping up With PemJAK NCT07283822 | Seda S. Tolu | Phase 2 |
| Recruiting | Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL NCT07271121 | King Hussein Cancer Center | Phase 2 |
| Recruiting | Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma NCT06334991 | ImmunityBio, Inc. | Phase 1 |